Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 51, Issue 2, 2014, Pages 284-293

  Agarwal, Amit R ^a   Yin, Fei ^a   Cadenas, Enrique ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alveolar cells; Cigarette smoke; Mitochondria; Palmitate; Pulmonary surfactant

Indexed keywords

ALVEOLAR CELLS; CIGARETTE SMOKE; MITOCHONDRIA; PALMITATE; PULMONARY SURFACTANT;

ANIMALS; ANTIGENS, CD36; CARNITINE O-PALMITOYLTRANSFERASE; CELL RESPIRATION; CELLS, CULTURED; ENERGY METABOLISM; GLYCOLYSIS; HYDROGEN-ION CONCENTRATION; INHALATION EXPOSURE; MALE; MICE; MITOCHONDRIA; OXYGEN CONSUMPTION; PALMITIC ACID; PHOSPHATIDYLCHOLINES; PHOSPHOLIPASES A2; PNEUMOCYTES; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; SMOKE; SMOKING; TIME FACTORS;

EID: 84904316832     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0523OC     Document Type: Article

References (54)

1. Fisher AB. Intermediary metabolism of the lung. Environ Health Perspect 1984;55:149-158.
2. Rooney SA. Lung surfactant. Environ Health Perspect 1984;55:205-226.
3. Pison U, Obertacke U, Brand M, Seeger W, Joka T, Bruch J, Schmit-Neuerburg KP. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J Trauma 1990;30:19-26.
4. Pison U, Seeger W, Buchhorn R, Joka T, Brand M, Obertacke U, Neuhof H, Schmit-Neuerburg KP. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am Rev Respir Dis 1989;140:1033-1039.
5. Lusuardi M, Capelli A, Carli S, Tacconi MT, Salmona M, Donner CF. Role of surfactant in chronic obstructive pulmonary disease: therapeutic implications. Respiration 1992;59:28-32.
6. Nakos G, Pneumatikos J, Tsangaris I, Tellis C, Lekka M. Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med 1997;155:945-951.
7. Gilljam H, Andersson O, Ellin A, Robertson B, Strandvik B. Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis. Clin Chim Acta 1988;176:29-37.
8. Brogden KA. Changes in pulmonary surfactant during bacterial pneumonia. Antonie van Leeuwenhoek 1991;59:215-223.
9. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997;77:931-962.
10. Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, Randell SH, Noble PW, Hogan BL. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest 2013;123:3025-3036.
11. Castranova V, Rabovsky J, Tucker JH, Miles PR. The alveolar type II epithelial cell: a multifunctional pneumocyte. Toxicol Appl Pharmacol 1988;93:472-483.
12. Crapo JD, Young SL, Fram EK, Pinkerton KE, Barry BE, Crapo RO. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 1983;128:S42-S46.
13. Evans MJ, Cabral LJ, Stephens RJ, Freeman G. Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. Exp Mol Pathol 1975;22:142-150.
14. Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem Res Toxicol 2001;14:767-790.
15. Haussmann HJ. Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem Res Toxicol 2012;25:794-810.
16. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006;28:219-242.
17. Agarwal AR, Zhao L, Sancheti H, Sundar IK, Rahman I, Cadenas E. Short-term cigarette smoke exposure induces reversible changes in energy metabolism and cellular redox status independent of inflammatory responses in mouse lungs. Am J Physiol Lung Cell Mol Physiol 2012;303:L889-L898.
18. Sun L, Luo C, Long J, Wei D, Liu J. Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 2006;6:136-142.
19. Picklo MJ, Montine TJ. Acrolein inhibits respiration in isolated brain mitochondria. Biochim Biophys Acta 2001;1535:145-152.
20. Cormier A, Morin C, Zini R, Tillement JP, Lagrue G. In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res 2001;900:72-79.
21. Ghafourifar P, Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci 2005;26:190-195.
22. van der Toorn M, Slebos DJ, de Bruin HG, Leuvenink HG, Bakker SJ, Gans RO, Koë ter GH, van Oosterhout AJ, Kauffman HF. Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis. Am J Physiol Lung Cell Mol Physiol 2007;292:L1211- L1218.
23. Miró O, Alonso JR, Jarreta D, Casademont J, Urbano-Márquez A, Cardellach F. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 1999;20:1331-1336.
24. Rhoades RA. Influence of starvation on the lung: effect on glucose and palmitate utilization. J Appl Physiol 1975;38:513-516.
25. Scholz RW, Rhoades RA. Lipid metabolism by rat lung in vitro: effect of starvation and re-feeding on utilization of (U-14 C) glucose by lung slices. Biochem J 1971;124:257-264.
26. Agarwal AR, Yin F, Cadenas E. Metabolic shift in lung alveolar cell mitochondria following acrolein exposure. Am J Physiol Lung Cell Mol Physiol 2013;305:L764-L773.
27. Teague SV, Pinkerton KE, Goldsmith M, Gebremichael A, Chang S, Jenkins RA, Money JH. Sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhal Toxicol 1994;6:79-93.
28. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648.
29. Chilosi M, Carloni A, Rossi A, Poletti V. Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema. Transl Res 2013;162:156-173.
30. Bartling B. Cellular senescence in normal and premature lung aging. Z Gerontol Geriatr 2013;46:613-622.
31. Leberl M, Kratzer A, Taraseviciene-Stewart L. Tobacco smoke induced COPD/emphysema in the animal model: are we all on the same page? Front Physiol 2013;4:91.
32. Podolin PL, Foley JP, Carpenter DC, Bolognese BJ, Logan GA, Long E III, Harrison OJ, Walsh PT. T cell depletion protects against alveolar destruction due to chronic cigarette smoke exposure in mice. Am J Physiol Lung Cell Mol Physiol 2013;304:L312-L323.
33. Rangasamy T, Misra V, Zhen L, Tankersley CG, Tuder RM, Biswal S. Cigarette smoke-induced emphysema in A/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol 2009;296:L888-L900.
34. Koike K, Ishigami A, Sato Y, Hirai T, Yuan Y, Kobayashi E, Tobino K, Sato T, Sekiya M, Takahashi K, et al. Vitamin c prevents cigarette smoke-induced pulmonary emphysema in mice and provides pulmonary restoration. Am J Respir Cell Mol Biol 2014;50:347-357.
35. Mori H, Nose T, Ishitani K, Kasagi S, Souma S, Akiyoshi T, Kodama Y, Mori T, Kondo M, Sasaki S, et al. Phosphodiesterase 4 inhibitor GPD-1116 markedly attenuates the development of cigarette smoke-induced emphysema in senescence-accelerated mice P1 strain. Am J Physiol Lung Cell Mol Physiol 2008;294:L196-L204.
36. Roh GS, Yi CO, Cho YJ, Jeon BT, Nizamudtinova IT, Kim HJ, Kim JH, Oh YM, Huh JW, Lee JH, et al. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Am J Physiol Lung Cell Mol Physiol 2010;299:L184-L191.
37. Ralser M, Wamelink MM, Latkolik S, Jansen EE, Lehrach H, Jakobs C. Metabolic reconfiguration precedes transcriptional regulation in the antioxidant response. Nat Biotechnol 2009;27:604-605.
38. Bolaños JP, Almeida A. The pentose-phosphate pathway in neuronal survival against nitrosative stress. IUBMB Life 2010;62:14-18.
39. Bolaños JP, Delgado-Esteban M, Herrero-Mendez A, Fernandez-Fernandez S, Almeida A. Regulation of glycolysis and pentosephosphate pathway by nitric oxide: impact on neuronal survival. Biochim Biophys Acta 2008;1777:789-793.
40. Hwang JW, Rajendrasozhan S, Yao H, Chung S, Sundar IK, Huyck HL, Pryhuber GS, Kinnula VL, Rahman I. FOXO3 deficiency leads to increased susceptibility to cigarette smoke-induced inflammation, airspace enlargement, and chronic obstructive pulmonary disease. J Immunol 2011;187:987-998.
41. Ludwig PW, Schwartz BA, Hoidal JR, Niewoehner DE. Cigarette smoking causes accumulation of polymorphonuclear leukocytes in alveolar septum. Am Rev Respir Dis 1985;131:828-830.
42. Yao H, Edirisinghe I, Rajendrasozhan S, Yang SR, Caito S, Adenuga D, Rahman I. Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. Am J Physiol Lung Cell Mol Physiol 2008;294:L1174-L1186.
43. Podowski M, Calvi C, Metzger S, Misono K, Poonyagariyagorn H, Lopez-Mercado A, Ku T, Lauer T, McGrath-Morrow S, Berger A, et al. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest 2012;122:229-240.
44. Bassett DJP, Hamosh M, Hamosh P, Rabinowitz JL. Pathways of palmitate metabolism in the isolated rat lung. Exp Lung Res 1981;2:37-47.
45. Guthmann F, Haupt R, Looman AC, Spener F, Rü stow B. Fatty acid translocase/CD36 mediates the uptake of palmitate by type II pneumocytes. Am J Physiol 1999;277:L191-L196.
46. Ibrahimi A, Abumrad NA. Role of CD36 in membrane transport of long-chain fatty acids. Curr Opin Clin Nutr Metab Care 2002;5:139-145.
47. Yu SH, Possmayer F. Lipid compositional analysis of pulmonary surfactant monolayers and monolayer-associated reservoirs. J Lipid Res 2003;44:621-629.
48. Agassandian M, Mallampalli RK. Surfactant phospholipid metabolism. Biochim Biophys Acta 2013;1831:612-625.
49. Moré JM, Voelker DR, Silveira LJ, Edwards MG, Chan ED, Bowler RP. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease. BMC Pulm Med 2010;10:53.
50. Ohlmeier S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllä rniemi M, Kinnula VL. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 2008;7:5125-5132.
51. Wada H, Goto H, Saitoh E, Ieki R, Okamura T, Ota T, Hagiwara S, Kodaka T, Yamamoto Y. Reduction in plasma free fatty acid in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:1465.
52. Cai B, Zhu Y, Ma Yi, Xu Z, Zao Yi, Wang J, Lin Y, Comer GM. Effect of supplementing a high-fat, low-carbohydrate enteral formula in COPD patients. Nutrition 2003;19:229-232.
53. Coxson HO, Chan IH, Mayo JR, Hlynsky J, Nakano Y, Birmingham CL. Early emphysema in patients with anorexia nervosa. Am J Respir Crit Care Med 2004;170:748-752.
54. Massaro D, Massaro GD. Hunger disease and pulmonary alveoli. Am J Respir Crit Care Med 2004;170:723-724.